Roger Michael Gendreau - 26 Feb 2024 Form 4 Insider Report for Virios Therapeutics, Inc. (DWTX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIRI	Stock Option (right to buy)	Award	$0	+88,085		$0.000000	88,085	26 Feb 2024	Common Stock	88,085	$0.3570	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock option will vest 100% on February 26, 2025, one year following the grant date.